This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This $885,349 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research to develop a blood test to measure sleep deprivation and circadian time. The award was granted to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in Boston, Massachusetts. The award has a performance period from June 1, 2025 to May 31, 2028. This research seeks to advance...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...
This federal Project Grant award for $4,232,760.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, is funding research by The Leland Stanford Junior University (Stanford University) to advance cure rates for infantile acute lymphoblastic leukemia. The award has a performance period from June 1, 2025 to May 31, 2029. Stanford University, a private research institution, will be conducting this advanced biomedical...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
The Leland Stanford Junior University has been awarded a $1,291,660.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on May 15, 2024, will fund foundational studies to understand phenotypic, region-specific, and cell-specific dysregulation in the myotonic dystrophy central nervous system, with a period of performance through May 14, 2028. This federal grant award supports the university's expertise in...
The Department of the Army Medical Command awarded a $983,207 project grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 to August 2024 targeting circadian control of oligodendrocyte lineage cell dynamics for remyelination. Through this funding, Stanford University researchers will investigate medical solutions for the battlefield by exploring how circadian rhythms regulate the generation of...